A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pulmonx Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 400 shares of LUNG stock, worth $2,944. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Previous 1,200 66.67%
Holding current value
$2,944
Previous $11,000 81.82%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.77 - $9.82 $97,784 - $166,419
16,947 Added 12.72%
150,210 $952,000
Q1 2024

May 15, 2024

BUY
$8.71 - $14.65 $682,271 - $1.15 Million
78,332 Added 142.6%
133,263 $1.24 Million
Q4 2023

Feb 14, 2024

BUY
$7.89 - $13.14 $405,364 - $675,093
51,377 Added 1445.61%
54,931 $700,000
Q3 2023

Nov 14, 2023

SELL
$9.88 - $14.0 $63,745 - $90,328
-6,452 Reduced 64.48%
3,554 $36,000
Q2 2023

Aug 14, 2023

SELL
$10.78 - $13.65 $1.66 Million - $2.1 Million
-153,623 Reduced 93.88%
10,006 $131,000
Q1 2023

May 15, 2023

BUY
$7.49 - $12.54 $695,146 - $1.16 Million
92,810 Added 131.05%
163,629 $1.83 Million
Q4 2022

Feb 14, 2023

SELL
$4.92 - $17.35 $351,578 - $1.24 Million
-71,459 Reduced 50.22%
70,819 $597,000
Q3 2022

Nov 14, 2022

SELL
$15.35 - $23.99 $1.86 Million - $2.91 Million
-121,193 Reduced 46.0%
142,278 $2.37 Million
Q2 2022

Aug 15, 2022

BUY
$14.0 - $27.95 $1.2 Million - $2.39 Million
85,518 Added 48.06%
263,471 $3.88 Million
Q1 2022

May 16, 2022

BUY
$21.13 - $35.65 $1.74 Million - $2.94 Million
82,432 Added 86.3%
177,953 $4.42 Million
Q4 2021

Feb 14, 2022

SELL
$29.72 - $45.1 $10.4 Million - $15.8 Million
-350,290 Reduced 78.57%
95,521 $3.06 Million
Q3 2021

Nov 15, 2021

BUY
$35.98 - $44.48 $6.41 Million - $7.93 Million
178,267 Added 66.63%
445,811 $16 Million
Q2 2021

Aug 16, 2021

BUY
$37.61 - $48.0 $3.37 Million - $4.3 Million
89,558 Added 50.32%
267,544 $11.8 Million
Q1 2021

May 17, 2021

BUY
$44.0 - $67.54 $2.12 Million - $3.26 Million
48,241 Added 37.18%
177,986 $8.14 Million
Q4 2020

Feb 16, 2021

BUY
$39.31 - $69.02 $5.1 Million - $8.95 Million
129,745 New
129,745 $8.96 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $274M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.